Biotech

All Articles

ReNeuron leaving behind objective swap after skipping fundraising goal

.ReNeuron has actually joined the long listing of biotechs to leave Greater london's objective stock...

MBX files for IPO to take challenger to Ascendis right into phase 3

.MBX Biosciences has added to the recent spurt of IPO filings. The biotech, which filed its own docu...

FDA broadens probing in to Lykos' MDMA trials: WSJ

.For Lykos Therapeutics and the firm's prospective MDMA-assisted treatment for post-traumatic stress...

Gene publisher Volume giving up 131 workers

.Merely times after genetics editor Volume Biosciences revealed unrevealed operational cuts, a more ...

Repare gives up 25% of team as biotech standstills preclinical R&ampD

.Repare Rehab is actually laying off a fourth of its own staff as the oncology biotech scales back i...

J &amp J files for FDA approval of $6.5 B autoimmune medication

.Johnson &amp Johnson has taken an additional action towards understanding a yield on its $6.5 billi...

Gain's period 1 gain paves way to verify Parkinson's drug's worth

.Increase Therapies has actually prepared its own sights on showing the effectiveness of its own Par...

Actinogen files brand-new period 2 information to salvage clinical depression medicine

.Actinogen Medical's chances-- as well as supply rate-- have rebounded a little from previously this...

Pfizer and Flagship incorporate Quotient to multibillion-dollar equation

.Crown Jewel Pioneering and also Pfizer have included Ratio into their 10-program collaboration, ink...

Bayer markers $547M deal to push boundaries of noncoding RNA

.Bayer executives were interested to stress to Ferocious this summer season that the German pharma g...